Zeffix

Zeffix (Lamivudine) is an oral antiviral medication used to treat chronic hepatitis B. It helps reduce viral load and improve liver function. This EU-manufactured treatment is taken once daily for long-term management. Always follow healthcare provider guidance when using Lamivudine.

Zeffix (Lamivudine) is primarily used to treat chronic hepatitis B virus (HBV) infection. It works by blocking the virus from multiplying, helping to lower HBV levels in the body. This medication is often prescribed for adults and children to manage long-term liver health. It may also be used in combination with other antiviral drugs for certain conditions.

Zeffix (Lamivudine) helps reduce the amount of hepatitis B virus in the body over time. Patients may experience improved liver function tests and fewer symptoms of liver inflammation. Some individuals report increased energy levels as viral activity decreases. Regular monitoring is recommended to track progress.

Zeffix (Lamivudine) should be taken exactly as prescribed by a healthcare provider. Do not stop or adjust the dose without medical advice, as sudden changes may affect treatment effectiveness. Inform your doctor about any kidney issues or other medications you are taking. Keep this medication stored in a cool, dry place away from children.

Zeffix (Lamivudine) may interact with other drugs that affect the kidneys, such as certain HIV medications or chemotherapy agents. Combining it with alcohol is not recommended, as it may increase the risk of side effects. Always review your full medication list with a healthcare professional before starting Lamivudine.